Want to see TSE:DOCT full AI Analyst Report?
Top Page
Beyond Medical Technologies Inc
(DOCT)
Select Model
Select Model
Rating:44Neutral
Price Target:
C$0.19
▲(14.12% Upside)
Action:Reiterated
Date:09/06/26
The score is primarily weighed down by very weak financial performance—minimal/unstable revenue, large ongoing losses, negative operating/free cash flow, and negative equity with high leverage. Technicals provide some offset with strong recent momentum (price above key moving averages and positive MACD), but overbought readings (high RSI/Stoch) add near-term risk. Valuation remains unattractive because the negative P/E reflects unprofitability and there is no dividend support.
Positive Factors
Improving FCF Trend
The positive TTM free-cash-flow growth rate provides a limited directional improvement in cash performance. Although cash generation remains negative, a better trend could indicate early progress in reducing operational burn if it persists through subsequent reporting periods.
Negative Factors
Severe Revenue Weakness
Extremely small and deteriorating revenue demonstrates that the company has not yet established dependable commercial traction. A negative TTM revenue figure further undermines earnings quality, making it difficult to support operating costs, fund expansion, or build a stable base for future profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving FCF Trend
The positive TTM free-cash-flow growth rate provides a limited directional improvement in cash performance. Although cash generation remains negative, a better trend could indicate early progress in reducing operational burn if it persists through subsequent reporting periods.
Read all positive factors
Beyond Medical Technologies Inc (DOCT) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.56M
Dividend YieldN/A
Average Volume (3M)2.47K
Price to Earnings (P/E)―
Beta (1Y)0.97
Revenue GrowthN/A
EPS Growth-156.09%
CountryCA
Employees3
SectorIndustrials
Sector Strength72
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)-0.25
Shares Outstanding32,793,960
10 Day Avg. Volume3,294
30 Day Avg. Volume2,472
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)45.96
Price to Sales (P/S)534.40
P/FCF Ratio-3.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beyond Medical Technologies Inc Business Overview & Revenue Model
Company Description
Republic Technologies Inc. provides Ethereum-based technology services. The company develops Validity Network, an attestation platform that provides cryptographically secure and tamper-resistant assurances of data integrity by anchoring data commi...
Beyond Medical Technologies Inc Financial Statement Overview
Summary
Income Statement
6
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
7
Very Negative
| Breakdown | Jun 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.48K | 0.00 | 0.00 | 0.00 | 943.42K |
| Gross Profit | 11.48K | 0.00 | 0.00 | 0.00 | -250.00K |
| EBITDA | -2.09M | -365.88K | -37.96K | -773.00K | -1.34M |
| Net Income | -2.68M | -285.00 | -596.00K | -1.40M | -2.91M |
Balance Sheet | |||||
| Total Assets | 15.85M | 13.80K | 95.64K | 608.18K | 1.95M |
| Cash, Cash Equivalents and Short-Term Investments | 2.76M | 13.22K | 64.14K | 536.75K | 1.43M |
| Total Debt | 11.86M | 60.00K | 30.00K | 0.00 | 85.09K |
| Total Liabilities | 15.71M | 634.46K | 430.35K | 346.94K | 413.28K |
| Stockholders Equity | 133.53K | -620.66K | -334.72K | 261.25K | 1.54M |
Cash Flow | |||||
| Free Cash Flow | -1.70M | -109.77K | -527.04K | -894.01K | -1.47M |
| Operating Cash Flow | -1.70M | -109.77K | -527.04K | -894.01K | -1.40M |
| Investing Cash Flow | -677.07K | 0.00 | 0.00 | 0.00 | -467.99K |
| Financing Cash Flow | 5.13M | 30.00K | 30.00K | 0.00 | 2.67M |
Beyond Medical Technologies Inc Technical Analysis
Positive
0.17
Price Trends
0.13
Positive
0.14
Positive
0.19
Positive
Market Momentum
0.01
Negative
80.99
Negative
75.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DOCT, the sentiment is Positive. The current price of 0.17 is above the 20-day moving average (MA) of 0.16, above the 50-day MA of 0.13, and below the 200-day MA of 0.19, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 80.99 is Negative, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DOCT.
Beyond Medical Technologies Inc Peers Comparison
UnderperformOutperform
Sector (63)
TSE:DOCT
Beyond Medical Technologies Inc
0.20
-0.41
-67.21%
TSE:APL
Appulse
0.22
>-0.01
-2.27%
TSE:ATMO
Atmofizer Technologies Inc. Class B
0.06
0.00
0.00%
Beyond Medical Technologies Inc Corporate Events
Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresRegulatory Filings and Compliance
Republic Technologies Shares Resume Trading After Cease Trade Order Revoked
Positive
Aug 11, 2026
Republic Technologies Inc. has regained regulatory compliance after the British Columbia Securities Commission revoked its failure-to-file cease trade order effective August 4, 2026. The company’s common shares resumed trading on the Canadia...
Financial DisclosuresRegulatory Filings and Compliance
Republic Technologies Refiles Amended Interim Financials After BCSC Review
Neutral
Aug 7, 2026
Republic Technologies Inc. has amended and refiled its interim financial statements and management’s discussion and analysis for the three- and nine-month periods ended September 30, 2025 and 2024 following a review by the British Columbia S...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.